Lupin Ltd gets USFDA nod for generic psoriasis treatment solution Pharmaceutical major Lupin Ltd gets USFDA nod for a generic psoriasis treatment solution. It is the first and only generic ...

Lupin is introducing rivaroxaban tablets, 2.5 mg, which is the generic of Janssen’s Xarelto.

In light of uncertainties surrounding US tariffs on pharmaceuticals, Kotak Institutional Equities noted in a recent report that the most likely scenario (for both companies and investors ...

Caught amidst tariff concerns shares of India's prominent drugmakers--Dr Reddy's Laboratories, Sun Pharma, Lupin, Cipla, Zydus Life and Aurobindo Pharma--slipped 1-4 percent. These companies have ...

Jefferies top pharma stocks: Jefferies has a Buy rating ... levels of triglycerides in adults with certain indications. Also, Lupin and Zydus will continue to gain market share in Mirabegron.

DelveInsight's High Potency Active Pharmaceutical Ingredients Market Insights report provides the current and forecast market ...

Here’s how it works. The hit Netflix thriller series Lupin will potentially be returning – but perhaps not in the way fans might have been expecting. The French crime drama became one of ...

Lupin's shares increased by 21.51% over the past year. However, year-to-date (YTD), the stock has decreased by 14.21%. Over ...

ANI Pharmaceuticals (ANIP) announced that the U.S. FDA has approved an expanded label for Iluvien that includes an indication for the treatment ...

Lupin's Omar Sy has been cast in a new Netflix offshoot of a popular action franchise. The star will lead a "high-octane" series from the Extraction universe, which will see the French actor play ...

Morgan Stanley analyst Vikram Purohit maintained a Hold rating on Ascendis Pharma (ASND – Research Report) today and set a price target of $180.00. The company’s shares closed last Friday at ...